Headline: Jiangsu Kebesen Strengthens Global Presence with Strategic Distribution Agreements for Aesthetic Skincare Line

Jiangsu Kebesen Biomedical Technology Co., Ltd., a trusted name in medical aesthetic technology, today announced the expansion of its global distribution network, securing new partnerships with leading skincare distributors in the European Union and North America.

This strategic move will make the company’s award-winning Tarliarcye Blemish Microdart Patches and other innovative skincare solutions available to millions of new consumers across 12 additional countries, including Germany, France, Canada, and the United States. The partnerships will also enable localized customer support, faster shipping, and tailored marketing campaigns to meet regional consumer needs.

“Expanding our global reach is a core milestone for Jiangsu Kebesen,” said the company’s CEO. “We are dedicated to making our science-backed, safe, and effective aesthetic skincare accessible to consumers worldwide, and these partnerships are a testament to the trust our products have earned in the global market.”

All Tarliarcye products are manufactured in Jiangsu Kebesen’s GMP-certified facilities, adhering to strict international quality standards, including EU CE certification and US FDA cosmetic safety guidelines. The company remains focused on R&D investment, with a pipeline of new microdart-based skincare products set to launch in 2026.